Product Recalls in Arkansas

Product recalls affecting Arkansas — including food, drugs, consumer products, medical devices, and vehicles distributed to Arkansas. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,623 recalls have been distributed to Arkansas in the last 12 months.

49,990 total recalls
2,623 in last 12 months

Showing 79017920 of 13,434 recalls

DrugJuly 6, 2017· Hospira Inc., A Pfizer Company

Recalled Item: Argatroban Injection Recalled by Hospira Inc., A Pfizer Company Due to...

The Issue: Failed Impurities/Degradation Specifications; out of specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 6, 2017· Baxter Healthcare Corporation

Recalled Item: 0.9% Sodium Chloride Injection USP Recalled by Baxter Healthcare Corporation...

The Issue: Lack of Assurance of Sterility: Customer complaints for leaking bags.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 5, 2017· HARDCORE FORMULATIONS

Recalled Item: D-ZINE Rapid Size and Strength capsules Recalled by HARDCORE FORMULATIONS...

The Issue: Marketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJuly 5, 2017· HARDCORE FORMULATIONS

Recalled Item: ULTRA-STEN Rapid Size and Strength capsules Recalled by HARDCORE...

The Issue: Marketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJune 29, 2017· Teva Pharmaceuticals USA

Recalled Item: Buprenorphine and Naloxone Sublingual Tablets Recalled by Teva...

The Issue: Failed Impurities/Degradation Specifications: out of specification test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 29, 2017· Teva Pharmaceuticals USA

Recalled Item: Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per...

The Issue: Failed Impurities/Degradation Specifications: out of specification test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 28, 2017· GSK Consumer Healthcare

Recalled Item: parodontax WHITENING (Stannous fluoride) Daily Fluoride Anticavity and...

The Issue: Presence of Foreign Substance: possibility of the presence of metal in the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 28, 2017· Valeant Pharmaceuticals North America LLC

Recalled Item: Obagi-C Rx System C-Therapy Night Cream Recalled by Valeant Pharmaceuticals...

The Issue: Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 0.9% Sodium Chloride Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 0.9% Sodium Chloride Injection 20 mMol in Recalled by...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 5% Dextrose Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 0.9% Sodium Chloride Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 0.9% Sodium Chloride Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 0.9% Sodium Chloride Injection 15 mMol in Recalled by...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 5% Dextrose Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 5% Dextrose Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 0.9% Sodium Chloride Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 5% Dextrose Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 0.9% Sodium Chloride Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2017· PharMedium Services, Llc

Recalled Item: Potassium PHOSphate in 0.9% Sodium Chloride Injection Recalled by PharMedium...

The Issue: Lack of Assurance of Sterility; media fill failure at manufacturer

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund